The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Chitosan-based nanoparticles for tumor-targeted drug delivery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
Tumor delivery of macromolecular drugs based on the EPR effect
Torchilin, V. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.03.011 · Cited by 2,032
Polysaccharides-based nanoparticles as drug delivery systems
Liu, Z., Jiao, Y., Wang, Y., Zhou, C., & Zhang, Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.001 · Cited by 1,732
Chitosan and Its Use as a Pharmaceutical Excipient
Ilium, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929016601 · Cited by 1,396
Novel chitin and chitosan nanofibers in biomedical applications
Jayakumar, R., Prabaharan, M., Nair, S. V., & Tamura, H. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.11.001 · Cited by 1,013
Self-citationChitin and chitosan in selected biomedical applications
Anitha, A., Sowmya, S., Kumar, P. T. S., Deepthi, S., Chennazhi, K. P., Ehrlich, H., Tsurkan, M., & Jayakumar, R. (2014) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2014.02.008 · Cited by 931
Nuclear factor-κB inhibitors as sensitizers to anticancer drugs
Nakanishi, C., & Toi, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1588 · Cited by 724
Mitra, S., Gaur, U., Ghosh, P. C., & Maitra, A. N. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00342-x · Cited by 647
Cited by
Ahmed, T., & Aljaeid, B. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s99651 · Cited by 705
Chitosan: Structural modification, biological activity and application
Wang, W., Xue, C., & Mao, X. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.09.042 · Cited by 647
Alginate Nanoparticles for Drug Delivery and Targeting
Severino, P., da Silva, C. F., Andrade, L. N., de Lima Oliveira, D., Campos, J., & Souto, E. B. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190425163424 · Cited by 304
Preparation and application of micro/nanoparticles based on natural polysaccharides
Yang, J., Han, S., Zheng, H., Dong, H., & Liu, J. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.01.029 · Cited by 276
Potential of Chitosan and its derivatives for controlled drug release applications – A review
Safdar, R., Omar, A. A., Arunagiri, A., Regupathi, I., & Thanabalan, M. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.10.020 · Cited by 147
Metadata
- Authors
- Prabaharan, M.
- Venue
- International Journal of Biological Macromolecules
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 72
- Pages
- 1313-1322
- ISSN
- 0141-8130 (ISSN-L)
- OpenAlex
- W2034191622
- Cited by
- 286
- References
- 60
- FWCI
- 7.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chitosan-based nanoparticles for tumor-targeted drug delivery. https://app.cochat.ai/papers/10.1016/j.ijbiomac.2014.10.052
- The paper
- Prabaharan, M. (2015). Chitosan-based nanoparticles for tumor-targeted drug delivery. International Journal of Biological Macromolecules. https://doi.org/10.1016/j.ijbiomac.2014.10.052
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.